What does CUSIP 30233G100 represent in this 13F holders report?

CUSIP 30233G100 is the security identifier for EYPT - EYEPOINT PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held EYPT - EYEPOINT PHARMACEUTICALS INC - COM in Q2 2019?

56 institutional investors reported EYPT - EYEPOINT PHARMACEUTICALS INC - COM for Q2 2019. Use the holders table for investor-level position and value details.

EYEPOINT PHARMACEUTICALS INC - COM (EYPT)

CUSIP: 30233G100

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class: Equity / COM
Total 13F shares: 61,425,753
Total 13F value: $100,733,000
Share change: +41,492,342
Put/Call ratio: 138%
SEC-reported price per share: $1.64
Number of holders: 56
Value change: +$67,407,943
Number of buys: 30
Number of sells: 32

Security key

30233G100

Report period

Q2 2019

Institutions

Top holders

EYPT full security history Ownership snapshot Full 13F holder table EyePoint, Inc. SEC filings EyePoint, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of EYPT - EYEPOINT PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

HighTower Advisors, LLC

Disclosed value leader

HighTower Advisors, LLC

Comparable rows

0/15

Latest evidence

31 Mar 2019

13F Highest disclosed value: $9,460,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

HighTower Advisors, LLC has the largest disclosed position value at $9.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HighTower Advisors, LLC's linked filing trail.

Disclosed position value Top 5

HighTower Advisors, LLC $9.46M

VANGUARD GROUP INC $4.99M

CVI Holdings, LLC $2.66M

BlackRock Finance, Inc. $2.08M

GUGGENHEIM CAPITAL LLC $2.04M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
HighTower Advisors, LLC	13F Company 13F	— denominator unverified	$9,460,000 5,284,838 shares	—	31 Mar 2019
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$4,991,000 2,788,055 shares	—	31 Mar 2019
CVI Holdings, LLC	13F Company 13F	— denominator unverified	$2,658,000 1,484,714 shares	—	31 Mar 2019
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$2,084,000 1,164,317 shares	—	31 Mar 2019
GUGGENHEIM CAPITAL LLC	13F Company 13F	— denominator unverified	$2,037,000 1,137,894 shares	—	31 Mar 2019
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$1,682,000 939,667 shares	—	31 Mar 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

61,425,753

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q2 2019 value	Value change	Value Chg %